Mitchell Elkind, MD, MS is a tenured Professor of Neurology and Epidemiology at Columbia University, and the Chief Clinical Science Officer of the American Heart Association. Dr. Elkind received his medical degree from Harvard Medical School and trained in Internal Medicine at Brigham and Women’s Hospital and in Neurology at Massachusetts General Hospital, both in Boston, MA. He completed fellowship in Vascular Neurology and Neuroepidemiology at Columbia University Medical Center, and holds a Master’s degree in Epidemiology from Columbia’s Mailman School of Public Health. Dr Elkind’s research focuses on stroke prevention, inflammatory and infectious biomarkers in stroke risk, atrial cardiopathy, immune therapy for acute stroke, and vascular causes of cognitive aging. Dr. Elkind is Principal Investigator of several NIH/NINDS studies, and he served as President of the American Heart Association 2020-2021.
